Literature DB >> 2478047

Anaphylaxis following administration of papaveretum. Case report: Implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant.

D G Harle1, B A Baldo, N J Coroneos, M M Fisher.   

Abstract

IgE antibodies that reacted with morphine and codeine were detected in the serum of a subject who experienced a life-threatening anaphylactic reaction following the administration of Omnopon-Scopolamine (papaveretum-hyoscine). Hapten inhibition studies with morphine and a number of structurally-related analogues revealed that morphine and codeine were the most potent inhibitors of IgE binding to a morphine-solid phase. Nalorphine, meperidine, and methadone were also good inhibitors of IgE binding, but naltrexone, buprenorphine, and fentanyl proved to be poor inhibitors. From a detailed examination of structure-activity relationships, the authors conclude that the important structural features of the morphine allergenic (that is, IgE binding) determinant comprises the cyclohexenyl ring with a hydroxyl group at C-6 and, most important of all, a methyl substituent attached to the N atom. The authors' findings suggest that morphine analogues administered to such a patient may provoke clinical anaphylaxis. Hyoscine reacted weakly with IgE antibodies in the subject's serum, but this was thought to be due to weak cross-reaction between this compound and morphine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478047

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  14 in total

1.  [Anesthetic incompatibility--rare, but dangerous].

Authors:  G Wurpts; J M Baron
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

Review 2.  Anaphylactoid reactions to narcotic analgesics.

Authors:  M M Fisher; D G Harle; B A Baldo
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

3.  Preoperative medical evaluation: part 1: general principles and cardiovascular considerations.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2009

Review 4.  Peri-operative anaphylaxis.

Authors:  Linda Nel; Efrem Eren
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

5.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 6.  Diagnosis of drug allergic reactions.

Authors:  D Vervloet; M Pradal; D Charpin; F Porri
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

7.  Sublingual desensitization for buprenorphine hypersensitivity.

Authors:  Lisa M Stutius; Itai Pessach; Joanne Lee; Mindy S Lo; Sharon Levy; Patricia Schram; Miriam Schizer; Jackson Wong; Wanda Phipatanakul; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2010-03-11       Impact factor: 10.793

Review 8.  Pain management: Part 1: Managing acute and postoperative dental pain.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2010

Review 9.  Drug allergies and implications for dental practice.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2013

10.  Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation.

Authors:  C H Sheen; R P Schleimer; M Kulka
Journal:  Allergy       Date:  2007-05       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.